National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Case
No judgment structure available for this case.

Statutory Rules

1973 No.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1973.*

WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953-1973 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1973, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL of Australia, acting with the advice of the Executive Council, hereby make the following Regulations under the National Health Act 1953-1973.

Dated this nineteenth day of July, 1973.

  

Paul Hasluck

Governor-General.

By His Excellency’s Command,

  

Minister of State for Health.

 

__________

  

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1.These Regulations shall come into operation on 1st August, 1973.

_______________________________________________________________________________

* Notified in the Commonwealth Gazette on  1973.

  Statutory Rules 1959 No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59and 107; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 153; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136 and 154; 1972, Nos. 32, 121 and 205; and 1973, Nos. 15 and 57.

14802/73—Price 35c 9/21.6.1973

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:—

FIRST SCHEDULE Regulation 10

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical Benefits

1. Acetarsol

2. Acetomenaphthone

3. Acetomenaphthone Tablets

4. Acetrizoic Acid

5. Alcohol Dehydrated

6. Alcohol (95%)

7. Allopurinol

8. Almond Oil

9. Aloes

10. Alprenolol Hydrochloride

11. Aluminium Hydroxide Tablets

12. Amethocaine Hydrochloride

13. Amitriptyline Injection

14. Amodiaquine Tablets

15. Amphetamine Sulphate

16. Amphetamine Sulphate Tablets

17. Amylobarbitone Sodium Tablets

18. Antazoline Hydrochloride

19. Antazoline Tablets

20. Antimony Sodium Tartrate

21. Antimony Sodium Tartrate Injection

22. Apomorphine Hydrochloride

23. Apomorphine Injection

24. Arachis Oil

25. Aspirin Phenacetin and Codeine Tablets

26. Aspirin Phenacetin and Codeine Tablets Soluble

27. Azathioprine

28. Bacillus Calmette-Guerin Vaccine

29. Barium Sulphate

30. Beclomethasone Dipropionate

31. Belladonna Herb

32. Belladonna Herb, Powdered

33. Bemegride

34. Bemegride Injection

35. Bendrofluazide

36. Benzhexol Hydrochloride

37. Benzyl Alcohol

38. Betamethasone Sodium Phosphate Tablets

39. Bethanidine Sulphate

40. Bisacodyl

41. Bisacodyl Suppositories

42. Bisacodyl Tablets

43. Botulinum Antitoxin

44. Bupivacaine Hydrochloride

45. Busulphan

46. Eutobarbitone

47. Butylated Hydroxyanisole

48. Butylated Hydroxytoluene

49. Caffeine Hydrate

50. Calciferol Solution

51. Calcium Cyclamate

52. Camphor

53. Caramiphen Hydrochloride

54. Caramiphen Tablets

55. Caraway

56. Carbamazepine

57. Carbimazole

58. Carbon Dioxide

59. Carbromal

60. Carbromal Tablets

61. Cardamom Fruit

62. Cascara

63. Castor Oil

64. Catgut, Sterilised, Surgical

65. Cellulose, Oxidised

66. Cetylpyridinium Chloride

67. Chlorambucil

68. Chlorcyclizine Hydrochloride

69. Chlordiazepoxide Capsules

70. Chlordiazepoxide Hydrochloride

71. Chlorhexidine Gluconate Solution

72. Chlorhexidine Hydrochloride

73. Chloroform

74. Chlormadinone Acetate

75. Chlormerodrin (107 Hg) Injection

76. Chloroquine Phosphate

77. Chloroquine Phosphate Injection

78. Chloroquine Sulphate

79. Chlorothiazide

80. Chlorotrianisene

81. Chlorotrianisene Capsules

82. Chlorphenesin

83. Chlorproguanil Hydrochloride

84. Chlorproguanil Tablets

85. Chlorpropamide

86. Chlorthalidone

87. Cholera Vaccine Mixed

88. Choline-Theophyllinate Tablets

89. Cinchocaine Hydrochloride

90. Cinnamon

91. Clofibrate

92. Cochineal

93. Colchicine

94. Colchicum Corm

95. Colchicum Liquid Extract

96. Colchicum Tincture

97. Colistin Tablets

98. Colophony

99. Concentrated Peppermint Water

100. Coriander

101. Coriander Oil

102. Corticotrophin

103. Corticotrophin Injection

104. Corticotrophin Gelatin Injection

105. Corticotrophin Zinc Hydroxide Injection

106. Cortisone Acetate

107. Cottonseed Oil

108. Cresol

109. Cresol and Soap Solution

110. Crotamiton

111. Cyanocobalamin

112. Cyanocobalamin (57 Co)

113. Cyanocobalamin (58 Co)

114. Cyclamic Acid

115. Cyclizine Tablets

116. Cyclobarbitone Calcium

117. Cyclomethycaine Sulphate

118. Cyclopenthiazide

119. Cyclopentolate Hydrochloride

120. Cyclopropane

121. Cycloserine

122. Cycloserine Tablets

123. Dapsone

124. Deoxycortone Acetate

First Schedule—continued

125. Deoxycortone Acetate Implants

126. Deoxycortone Acetate Injection

127. Dequalinium Acetate

128. Dequalinium Chloride

129. Desipramine Hydrochloride

130. Dexamphetamine Sulphate

131. Dexamphetamine Tablets

132. Dextran 110 Injection

133. Dextromethorphan Hydrobromide

134. Dextromethorphan Tablets

135. Dextropropoxyphene Capsules

136. Dextropropoxyphene Hydrochloride

137. Dextropropoxyphene Napsylate

138. Dextrose Monohydrate

139. Diamorphine Hydrochloride

140. Diamorphine Injection

141. Diazepam Capsules

142. Dibromopropamidine Isethionate

143. Dichloralphenazone

144. Dichlorophen

145. Dichlorophen Tablets

146. Dichlorphenamide

147. Diethylcarbamazine Citrate

148. Diethylcarbamazine Tablets

149. Digitalis Leaf

150. Digitalis Prepared

151. Digitoxin

152. Digitoxin Tablets

153. Dihydrocodeine Injection

154. Dihydrocodeine Tablets

155. Di-iodohydroxyquinoline Tablets

156. Diloxanide Furoate

157. Dilute Alcohols

158. Dimenhydrinate

159. Dimenhydrinate Injection

160. Dimenhydrinate Tablets

161. Dimercaprol

162. Dimethisterone Tablets

163. Diodone Injection

164. Diphenoxylate Hydrochloride

165. Diphtheria and Pertussis Vaccine

166. Diphtheria, Tetanus and Poliomyelitis Vaccine

167. Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine

168. Dipipanone Hydrochloride.

169. Dipipanone Injection

170. Dodecyl Gallate

171. Domiphen Bromide

172. Dried Human Albumin

173. Dusting Powder Absorbable

174. Dydrogesterone

175. Dydrogesterone Tablets

176. Edrophonium Chloride

177. Edrophonium Injection

178. Eltor Vaccine

179. Emetine and Bismuth Iodide

180. Emetine Hydrochloride

181. Erythromycin

182. Ethacrynic Acid

183. Ethchlorvynol

184. Ether Anaesthetic

185. Ether Solvent

186. Ethionamide

187. Ethionamide Tablets

188. Ethisterone

189. Ethisterone Tablets

190. Ethopropazine Hydrochloride

191. Ethotoin

192. Ethyl Chloride

193. Ethyl Oleate

194. Ethylene-diamine Hydrate

195. Eucalyptus Oil

196. Eugenol

197. Ferric Citrate (59 Fe) Injection

198. Ferrous Fumarate

199. Ferrous Succinate Tablets

200. Fludrocortisone Acetate

201. Fluoxymesterone

202. Gallamine Triethiodide

203. Gallamine Injection

204. Gamma Benzene Hexachloride

205. Gelatin Sponge, Absorbable

206. Gentian

207. Gentian Tincture, Compound

208. Ginger

209. Gold (198 Au) Injection

210. Guanethidine Sulphate

211. Halothane

212. Helium

213. Heparin

214. Hexachlorophane

215. Hexylresorcinol

216. Histamine Acid Phosphate

217. Histamine Acid Phosphate Injection

218. Human Albumin

219. Human Antihaemophilic Fraction

220. Human Blood, Whole

221. Human Fibrin Foam

222. Human Fibrinogen

223. Human Normal Gamma Globulin Injection

224. Human Plasma, Dried

225. Human Plasma Protein Fraction

226. Human Plasma Protein Fraction, Dried

227. Human Red Blood Corpuscles, Concentrated

228. Human Serum, Dried

229. Human Thrombin

230. Hydrochlorothiazide

231. Hydrocortisone Hydrogen Succinate

232. Hydroflumethiazide

233. Hydrogen Peroxide Solution, Strong

234. Hydroxocobalamin

235. Hydroxychloroquine Sulphate

236. Hydroxyprogesterone Hexanoate

237. Hyoscine Injection

238. Hyoscine Eye Ointment

239. Hyoscine Tablets

240. Hyoscyamus

241. Hyoscyamus Dry Extract

242. Indigo Carmine

243. Indomethacin

244. Influenza Vaccine

245. Industrial Methylated Spirit

246. Inulin

247. Inulin Injection

248. Iodinated (125 I) Human Serum Albumin Injection

249. Iodinated (131 I) Human Serum Albumin Injection

250. Iodipamide Meglumine Injection

251. Iodised Oil Fluid Injection

252. Iopanoic Acid

253. Iopanoic Acid Tablets

254. Iophendylate Injection

255. Iothalamic Acid

256. Ipecacuanha, Prepared

257. Isocarboxazid

258. Isocarboxazid Tablets

First Schedule—continued

259. Isoniazid

260. Isopropyl Alcohol

261. Kaolin, Heavy

262. Laevulose

263. Lemon Peel, Dried

264. Levallorphan Injection

265. Levodopa

266. Levorphanol Injection

267. Levorphanol Tablets

268. Levorphanol Tartrate

269. Lignocaine and Adrenaline Injection

270. Liothyronine Sodium

271. Liquorice

272. Lithium Carbonate

273. Lucanthone Hydrochloride

274. Lucanthone Tablets

275. Magnesium Stearate

276. Maize Oil

277. Male Fern

278. Male Fern Extract

279. Maleic Acid

280. Measles Vaccine (Inactivated)

281. Measles Vaccine (Live Attenuated)

282. Mecamylamine Hydrochloride

283. Mefenamic Acid

284. Mefenamic Acid Capsules

285. Meglumine Iothalamate Injection

286. Melarsoprol

287. Melarsoprol Injection

288. Melphalan

289. Melphalan Injection

290. Mepacrine Hydrochloride

291. Mephentermine Sulphate

292. Meprobamate

293. Meprobamate Tablets

294. Mepyramine Injection

295. Mepyramine Maleate

296. Mepyramine Tablets

297. Mercaptopurine

298. Mersalyl Acid

299. Metaraminol Tartrate

300. Methadone Hydrochloride

301. Methandienone

302. Methicillin Sodium

303. Methohexitone Injection

304. Methoin

305. Methoserpidine

306. Methoserpidine Tablets

307. Methoxyflurane

308. Methylcellulose 450

309. Methyl Hydroxybenzoate

310. Methylamphetamine Hydrochloride

311. Methylamphetamine Injection

312. Methylamphetamine Tablets

313. Methyldopa

314. Methylergometrine Maleate

315. Methylprednisolone Tablets

316. Methylthiouracil

317. Methylthiouracil Tablets

318. Methyprylone

319. Methyprylone Tablets

320. Metronidazole

321. Metyrapone

322. Morphine Sulphate Tablets

323. Nalorphine Hydrobromide

324. Nandrolone Decanoate

325. Nandrolone Phenylpropionate

326. Naphazoline Hydrochloride

327. Nealbarbitone

328. Nealbarbitone Tablets

329. Neostigmine Bromide

330. Nialamide

331. Nialamide Tablets

332. Niclosamide

333. Nicotinic Acid

334. Nicoumalone

335. Nikethamide

336. Nikethamide Injection

337. Nitrazepam

338. Nitrous Oxide

339. Norethandrolone

340. Norethandrolone Tablets

341. Noscapine

342. Novobiocin Calcium

343. Novobiocin Sodium

344. Novobiocin Tablets

345. Nux Vomica

346. Octyl Gallate

347. Oestradiol Benzoate

348. Oestradiol Benzoate Injection

349. Olive Oil

350. Opium

351. Opium, Powdered

352. Orange Peel, Dried Bitter

353. Orphenadrine Hydrochloride

354. Oxygen

355. Oxyphenbutazone

356. Oxyphenbutazone Tablets

357. Oxyphencyclimine Hydrochloride

358. Oxytetracycline Tablets

359. Oxytocin Tablets

360. Paramethadione

361. Paromomycin Capsules

362. Paromomycin Sulphate

363. Pempidine Tartrate

364. Penicillamine

365. Penicillamine Hydrochloride

366. Pentagastrin

367. Pentagastrin Injection

368. Pentamidine Isethionate

369. Pentamidine Injection

370. Pentolinium Tartrate Tablets

371. Peppermint Oil

372. Percutaneous Bacillus Calmette-

Guerin Vaccine

373. Perphenazine

374. Perphenazine Tablets

375. Pethidine Tablets

376. Phenacetin

377. Phenazocine Hydrobromide

378. Phenazocine Injection

379. Phenazocine Tablets

380. Phenelzine Sulphate

381. Phenelzine Tablets

382. Phenindamine Tartrate

383. Phenindione

384. Phenmetrazine Hydrochloride

385. Phenmetrazine Tablets

386. Phenolphthalein Tablets

387. Phenolsulphonphthalein

388. Phenoxybenzamine Capsules

389. Phenoxybenzamine Hydrochloride

390. Phenoxymethylpenicillin

391. Phenoxymethylpenicillin Potassium

392. Phentolamine Mesylate

393. Phentolamine Injection

394. Phenylephrine Injection

395. Phosphoric Acid

396. Phytomenadione Capsules

397. Phytomenadione Tablets

First Schedule—continued

398. Piperazine Citrate

399. Piperazine Phosphate Tablets

400. Poldine Methylsulphate

401. Poldine Tablets

402. Poliomyelitis Vaccine (Inactivated)

403. Poliomyelitis Vaccine (Oral)

404. Potassium Bromide

405. Potassium Chloride Injection

406. Potassium Hydroxide

407. Potassium Nitrate

408. Prednisolone Pivalate

409. Prednisolone Pivalate Injection

410. Prednisone Acetate

411. Primaquine Phosphate

412. Probenecid

413. Procainamide Tablets

414. Procaine and Adrenaline Injection

415. Prochlorperazine Maleate

416. Prochlorperazine Mesylate

417. Procyclidine Hydrochloride

418. Progesterone

419. Progesterone Injection

420. Proguanil Hydrochloride

421. Promazine Hydrochloride

422. Promazine Injection

423. Promazine Tablets

424. Promethazine Theoclate

425. Propranolol Hydrochloride

426. Propyl Gallate

427. Propyliodone

428. Propyliodone Injection

429. Propyliodone Oily Injection

430. Propylthiouracil

431. Pyrazinamide

432. Pyridostigmine Bromide

433. Pyrimethamine

434. Pyroxylin

435. Quillaia

436. Quinine Dihydrochloride

437. Quinine Dihydrochloride Injection

438. Rabies Antiserum

439. Rabies Vaccine

440. Rubella Vaccine (Live Attenuated)

441. Senna Fruit

442. Sesame Oil

443. Silver Nitrate, Toughened

444. Slow Lithium Carbonate Tablets

445. Slow Orphenadrine Citrate Tablets

446. Soda Lime

447. Sodium Acetrizoate Injection

448. Sodium Antimonylgluconate

449. Sodium Antimonylgluconate Injection

450. Sodium Aurothiomalate

451. Sodium Bicarbonate Compound Tablets

452. Sodium Bromide

453. Sodium Calciumedetate

454. Sodium Chromate (51 Cr) Solution

455. Sodium Citrate Tablets

456. Sodium Cyclamate

457. Sodium Diatrizoate

458. Sodium Diatrizoate Injection

459. Sodium Fluoride

460. Sodium Fusidate Capsules

461. Sodium Hydroxide

462. Sodium Iodide (131 I) Injection

463. Sodium Iodide (125 I) Solution

464. Sodium Iodide (131 I) Solution

465. Sodium Iodohippurate (131 I) Injection

466. Sodium Iothalamate Injection

467. Sodium Lauryl Sulphate

468. Sodium Phosphate (32 P) Injection

469. Sodium Stibogluconate

470. Sodium Stibogluconate Injection

471. Solapsone

472. Solapsone Tablets

473. Sorbitol Injection

474. Spironolactone

475. Staphylococcus Antitoxin

476. Stibophen

477. Stibophen Injection

478. Stramonium

479. Sulphadiazine Sodium

480. Sulphadimethoxine

481. Sulphadimidine Injection

482. Sulphadimidine Sodium

483. Sulphamethizole

484. Sulphamethoxydiazine

485. Sulphamethoxypyridazine

486. Sulphapyridine

487. Sulphinpyrazone

488. Sulphobromophthalein Sodium

489. Sulphomyxin Injection

490. Sulphomyxin Sodium

491. Sulthiame

492. Suramin

493. Suramin Injection

494. Suxamethonium Chloride

495. Suxamethonium Bromide

496. Suxamethonium Chloride Injection

497. Testosterone

498. Testosterone Phenylpropionate Injection

499. Tetanus and Pertussis Vaccine

500. Tetanus Vaccine (Alum Precipitated)

501. Tetanus Vaccine (Precipitated Toxoid

Aluminium Hydroxide)

502. Tetanus Vaccine (Simple Solution)

503. Tetrachloroethylene

504. Tetrachloroethylene Capsules

505. Tetracycline Tablets

506. Thiambutosine

507. Thiomersal

508. Thiopentone Sodium

509. Thiopentone Injection

510. Thioridazine Hydrochloride

511. Thyroid

512. Thyroxine Sodium

513. Tolnaftate

514. Tolazoline Hydrochloride

515. Tolazoline Tablets

516. Tolbutamide

517. Tolu Balsam

518. Tranylcypromine Sulphate

519. Tranylcypromine Tablets

520. Triamterene Capsules

521. Trichloroethylene

522. Tricyclamol Chloride

523. Tricyclamol Tablets

524. Trimipramine Maleate

525. Tryparsamide

526. Tryparsamide Injection

527. Tuberculin, Old

528. Tuberculin Purified Protein Derivative

529. Tubocurarine Chloride

530. Tubocurarine Injection

531. Turpentine Oil

532. Typhoid-Paratyphoid A and B

533. Typhoid-Paratyphoid A and B and

Cholera Vaccine

First Schedule—continued

534. Typhoid-Paratyphoid A and B and

Tetanus Vaccine

535. Typhoid-Paratyphoid A, B and C

Vaccine

536. Undecenoic Acid

537. Urea

538. Urea Injection

539. Vancomycin Hydrochloride

540. Vancomycin Injection

541. Vinyl Ether

542. Vitamin A Ester Concentrate

543. Yellow Fever Vaccine

544. Zinc Undecenoate

545. Zinc Undecenoate Ointment

‑‑‑‑‑‑‑‑‑‑‑

SECOND SCHEDULE Regulation 10 (3)

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

1

Acepifylline.........................

—

2

Acetylsulphafurazole........

—

3

Acetylcysteine....................

—

4

Acrylic Resin......................

—

5

Adrenaline Hydrochloride

—

6

Albumaid XP......................

—

7

Alginic Acid Compound..

—

8

Aluminium Sodium Silicate

—

9

Amino Acids.......................

Amino Acids with Sorbitol

Amino Acids with Sorbitol and Alcohol

10

Aminocaproic Acid............

—

11

Aminogran..........................

—

12

Amphotericin B

Tetracycline, B.P.C., with buffering agent and Amphotericin B

13

Ampicillin............................

—

14

Ampicillin Trihydrate.......

Purified Water, B.P., with Ampicillin Trihydrate

15

Antazoline Sulphate..........

Naphazoline Nitrate with Antazoline Sulphate

16

Ascorbic Acid.....................

Vitamin A with Thiamine Hydrochloride, Riboflavine Nicotinamide, Vitamin D and Ascorbic Acid

Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary

Ferrous Sulphate mixture Prescribers’ List

Ferrous Sulphate mixture Prescribers’ List Children’s Section

17

Attapulgite...........................

Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite

18

Bacitracin............................

Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin

19

Bacitracin Zinc...................

Neomycin Undecenoate with Bacitracin Zinc

Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc

20

“ BANISH ”........................

—

21

Belladonna Herb, Prepared

Phenobarbitone with Belladonna Herb, Prepared

22

Belladonna, Dry Extract ..

Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna

23

Betamethasone..................

Betamethasone Acetate with Betamethasone

24

Betamethasone Acetate ...

Betamethasone with Betamethasone Acetate

25

Betamethasone Sodium Phosphate............................

—

26

Betamethasone Phosphate

—

27

Brompheniramine Maleate

—

28

Calciferol.............................

—

29

Calcium Di-Oxytetracycline

—

30

Calcium Lactate-Gluconate

Calcium Carbonate, B.P., with Calcium Lactate-Gluconate

31

Capsicum Oleoresin...........

Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954, and Capsicum Olcoresin

32

Carbachol............................

Hypromellose 4500 with Carbachol

33

Carbinoxamine Maleate ..  

—

34

Cascara Dry Extract..........

Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954, and Cascara Dry Extract

35

Ceratonia, B.P.C. 1949.....

—

36

Chloramine, B.P.C.

—

37

Chloramphenicol...............

Polymyxin B Sulphate with Chloramphenicol

38

Chloramphenicol Palmitate, B.P.C.

—

39

Chloramphenicol Stearate

—

40

Chlorhexidine Gluconate

—

41

Chlorpheniramine Maleate

—

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

42

Chlorpromazine Hydro-chloride

—

43

Choline Theophyllinate....

Guaiphenesin with Choline Theophyllinate

44

Clemastine Hydrogen Fumarate

—

45

Clemizole Tannate............

—

46

Cloxacillin Sodium............

Purified Water, B.P., with Cloxacillin Sodium

47

Colistin Sulphate...............

Neomycin Sulphate with Colistin Sulphate

48

Cortisone Acetate..............

—

49

Cyclizine Hydrochloride

Ergotamine; Tartrate with Caffeine and Cyclizine Hydrochloride

50

Cymogran...........................

—

51

Cyproheptadine Hydrochloride

—

52

Danthron.............................

Dioctyl Sodium Sulphosuccinate B.P.C., with Danthron

53

Demecarium Bromide.......

—

54

Demethylchlortetracycline Hydrochloride

Nystatin with Demethylchlortetracycline Hydrochloride

55

Dexamethasone.................

Framycetin Sulphate with Gramicidin and Dexamethasone

56

Dexamethasone Metasulphobenzoate

Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate

57

Dexchlorpheniramine Maleate

—

58

Dextrans..............................

Dextrose with Dextrans

Sodium Chloride with Dextrans

59

Dextrose Polymer

—

60

Diazepam............................

—

61

Dichloralphenazon ............

—

62

Dicyclomine Hydrochloride

Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride

63

Dienoestrol..........................

—

64

Diethanolamine Fusidate

—

65

Digoxin.................................

—

66

Dihydrocodeine Tartrate

—

67

Dihydrostreptomycin Sulphate, B.P. 1958

Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958

Kaolin with Pectin, Aluminium Hydroxide Get and Dihydrostreptomycin Sulphate, B.P. 1958

68

Dihydrotachysterol............

—

69

Dimethicone, B.P.C...........

—

70

Dimethisterone ..................

Ethinyloestradiol with Dimethisterone

71

Dioctyl Sodium Sulphosuccinate, B.P.C.

Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C.

72

Diphenhydramine Hydrochloride

Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride

73

Diphenylpyraline Hydrochloride

—

74

Diphtheria Vaccine............

Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine

75

Doxycycline Hydrochloride

—

76

Doxylamine Succinate .....

Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate

77

Ecothiopate Iodide............

—

78

Ergometrine Maleate........

Oxytocin with Ergometrine Maleate

79

Ergotamine Tartrate..........

Caffeine with Ergotamine Tartrate

Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate

Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate

Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate

 

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

80

Erythromycin Estolate.......

—

81

Erythromycin Stearate.......

—

82

Ethinyloestradiol.................

Dimethisterone with Ethinyloestradiol

Ethynodiol Diacetate with Ethinyloestradiol

Megestrol Acetate with Ethinyloestradiol

Norethisterone Acetate with Ethinyloestradiol

Norgestrel with Ethinyloestradiol

83

Ethosuximide.......................

—

84

Ethynodiol Diacetate..........

Ethinyloestradiol with Ethynodiol Diacetate

Mestranol with Ethynodiol Diacetate

85

Ferric Hydroxide.................

—

86

Ferrous Aminoacetosulphate

—

87

Ferrous Succinate.................

—

88

Fluclorolone Acetonide ......

—

89

Fluocinolone Acetonide......

—

90

Fluocortolone Hexanoate ...

Fluocortolone Pivalate with Fluocortolone Hexanoate

91

Fluocortolone Pivalate.........

Fluocortolone Hexanoate with Fluocortolone Pivalate

92

Fluphenazine Hydrochloride

—

93

Flurandrenolone ...................

—

94

Folic Acid...............................

Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P.

95

Framycetin Sulphate............

Light Kaolin with Framycetin Sulphate

Dexamethasone with Framycetin Sulphate and Gramicidin

Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate

96

Galactomin, Formula No.17

—

97

Galactomin, Formula No.19

—

98

Glucose and Ketone Indicator

—

99

Glucose Indicator, Blood

—

100

Glucose Indicator, Urine

—

101

Goat’s Milk, Dehydrated

—

102

Goat’s Milk............................

—

103

Gramicidin............................

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin

Framycetin Sulphate with Dexamethasone and Gramicidin

Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin

Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin

104

Guaiphenesin, B.P.C............

Theophylline with Guaiphenesin, B.P.C.

105

Hydrocortisone.....................

Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone

Neomycin Sulphate with Hydrocortisone

Natamycin with Neomycin Sulphate and Hydrocortisone

106

Hydrocortisone Acetate.......

Neomycin Sulphate with Hydrocortisone Acetate

Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate

Oxytetracycline Hydrochloride and Hydrocortisone Acetate

107

Hyoscine Hydrobromide.....

Hypromellose 4500 with Hyoscine Hydrobromide

Papaveretum with Hyoscine Hydrobromide

Pethidine Hydrochloride with Hyoscine Hydrobromide

108

Idoxuridine............................

—

109

Ipecacuanha..........................

Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959, and Ipecacuanha

110

“ ISOMIL ”............................

—

111

Isoniazid.................................

Sodium Aminosalicylate with Isoniazid

112

Isoprenaline Hydrochloride

—

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

113

Kanamycin Sulphate, B.P.C.

—

114

“ KETOVITE ” Liquid .......

—

115

Lauryl Dimethylbenzyl Ammonium Chloride

“ TERIC N8 ” with Lauryl Dimethylbenzyl Ammonium Chloride

116

Levallorphan Tartrate .........

Pethidine Hydrochloride with Levallorphan Tartrate

117

Lignocaine Hydrochloride

Polymyxin P. Sulphate with Propylene Glycol and Lignocaine Hydrochloride

118

Lincomycin Hydrochloride

—

119

Locasol ..................................

—

120

Lofenalac...............................

—

121

Lynoestrenol..........................

Mestranol with Lynoestrenol

122

Lypressin................................

—

123

Magnesium Aluminium Hydroxide

—

124

Magnesium Chloride............

Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride

Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride

Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride

125

Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine

Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C.

126

Mebhydrolin Napadisylate, B.P.C.

—

127

Meclozine Hydrochloride

Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride

128

Medrysone.............................

—

129

Megestrol Acetate ...............

Ethinyloestradiol with Megestrol Acetate

130

Meglumine.............................

Theophylline with Meglumine

131

Mestranol...............................

Ethynodiol Diacetate with Mestranol

Lynoestrenol with Mestranol

Norethisterone with Mestranol

Norethynodrel with Mestranol

132

Methacycline Hydrochloride

—

133

Methdilazine Hydrochloride

—

134

Methenamine Mandelate....

—

135

Methylprednisolone ............

—

136

Morphine Tartrate ...............

Morphine Tartrate with Tacrine

137

Nalidixic Acid, B.P.C.

—

138

Naphazoline Nitrate.............

Naphazoline Nitrate with Antazoline Sulphate

139

Natamycin.............................

Neomycin Sulphate with Hydrocortisone and Natamycin

140

Neomycin Sulphate..............

Hydrocortisone Acetate with Neomycin Sulphate

Hydrocortisone with Neomycin Sulphate

Colistin Sulphate with Neomycin Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Kaolin with Neomycin Sulphate

Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate

Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate

Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate

Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate

Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate

Natamycin with Hydrocortisone and Neomycin Sulphate

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

141

Neomycin Undecenoate................

Bacitracin Zinc with Neomycin Undecenoate

142

Neostigmine Methylsulphate........

—

143

Nicotinamide....................................

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D

144

Nitrofurantoin..................................

—

145

Noradrenaline Acid Tartrate.........

—

146

Norethisterone..................................

Mestranol with Norethisterone

147

Norethisterone Acetate..................

Ethinyloestradiol with Norethisterone Acetate

148

Norethynodrel..................................

Mestranol with Norethynodrel

149

Norgestrel..........................................

Ethinyloestradiol with Norgestrel

150

Nortriptyline Hydrochloride..........

—

151

Nystatin.............................................

Tetracycline, B.P.C. with a buffering agent and Nystatin

Demethylchlortetracycline with Nystatin

Tetracycline Hydrochloride with Nystatin

Gramicidin with Neomycin Sulphate, Triamcinolone Acctonide and Nystatin

Oxytetracycline Dihydrate with Nystatin

152

Nutramigen.......................................

—

153

Octatropine Methylbromide..........

—

154

Orciprenaline Sulphate..................

—

155

Oxytetracycline Dihydrate............

Nystatin with Oxytetracycline Dihydrate

156

Oxytetracycline Hydrochloride....

Polymyxin B Sulphate with Oxytetracycline Hydrochloride

Hydrocortisone Acetate with Oxytetracycline Hydrochloride

157

Oxethazaine.....................................

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine

158

Oxytocin...........................................

Ergometrine Maleate with Oxytocin

159

Pancreatin.........................................

—

160

Pancreatin Enzyme, 4 times U.S.N.F.XII strength..................

—

161

Papaveretum, B.P.C........................

Hyoscine Hydrobromide with Papaveretum, B.P.C.

162

Penicillin, Benthamine, B.P.C......

Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin

163

Penicillin, Benzathine....................

Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin

164

Penicillin, Benzyl............................

Procaine Penicillin with Benzyl Penicillin

165

Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt)..............................

—

166

Penicillin, Potassium......................

Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin

167

Penicillin, Procaine.........................

Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin

Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin

Benzyl Penicillin with Procaine Penicillin

168

Penicillin, Sodium...........................

Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin

169

Pentobarbitone................................

Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone

170

Pericyazine.......................................

—

171

Pertussis Vaccine............................

Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine

172

Pethidine Hydrochloride................

Levallorphan Tartrate with Pethidine Hydrochloride

Hyoscine Hydrobromide with Pethidine Hydrochloride

173

Phenethicillin Benzathine.............

—

174

Phenethicillin Potassium...............

Purified Water, B.P., with Phenethicillin Potassium

175

Pheniramine Maleate.....................

—

176

Phenytoin, B.P.C. ...........................

—

177

Pholcodine........................................

—

178

Pipenzolate Methobromide...........

—

179

Pituitary (Posterior Lobe), Powdered, B.P.C.........................

—

 

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

180

“PK AID I” ....................................

—

181

“PK AID II” ..................................

—

182

Plasma Substitute (Polypeptide).

—

183

Polyisobutylene ............................

—

184

Polymyxin B Sulphate.................

Chloramphenicol with Polymyxin B Sulphate

Oxytetracycline Hydrochloride with Polymyxin B Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Propylene Glycol with Acetic Acid and Polymyxin B Sulphate

Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate

Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate

Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate

185

Polyvinyl Alcohol ........................

Pilocarpine Nitrate and Polyvinyl Alcohol

186

Prednisolone ..................................

—

187

Prednisolone Acetate....................

Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.

188

Prednisolone Sodium Phosphate

—

189

Primidone ......................................

—

190

Promethazine Hydrochloride......

—

191

Pseudoephedrine Hydrochloride

—

192

Pyrantel Embonate.......................

—

193

Pyridoxine Hydrochloride...........

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

194

Prosobee .........................................

—

195

Riboflavine.....................................

Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine

196

Salbutamol ....................................

—

197

Silver Nitrate, Toughened...........

—

198

Sobee ..............................................

—

199

Sodium Acetate.............................

Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate

200

Sodium Acid Citrate.....................

—

201

Sodium Gluconate........................

Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate

202

Sodium Lactate ............................

Potassium Chloride with Sodium Chloride and Sodium Lactate

Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate

Potassium Chloride with Dextrose and Sodium Lactate

Sodium Chloride with Dextrose and Sodium Lactate

Sodium Chloride with Sodium Lactate

203

Sodium Tauroglycocholate, B.P.C. 1954.................................

Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954

204

Sorbitol ............................................

Amino Acids with Sorbitol

Amino Acids with Sorbitol and Alcohol

205

Soyalac ............................................

—

206

Sterculia

—

207

Strychnine, B.P.C. 1959

Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959

208

Sulphafurazole ..............................

—

209

Sulphamethizole ...........................

—

210

Sulphamethoxazole.......................

Trimethoprim with Sulphamethoxazole

211

Sulphaphenazole, B.P.C................

—

212

Surgical Cement

—

213

Surgical Cement Solvent..............

—

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

214

Tacrine .............................................................

Morphine Sulphate with Tacrine

Morphine Tartrate with Tacrine

215

Terbutaline Sulphate.............................................................

—

216

“ TERIC N8 ” .............................................................

Lauryl Dimethylbenzyl Ammonium Chloride with “ TERIC N8 ”

217

Testosterone Decanoate.............................................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

218

Testosterone Isocaproate.............................................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

219

Testosterone Phenylpropionate.............................................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

220

Testosterone Propionate.............................................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

221

Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

222

Tetracycline, B.P.C. .............................................................  

Tetracycline, B.P.C. with a buffering agent

Tetracycline, B.P.C. with a buffering agent and Amphotericin B

Tetracycline, B.P.C. with a buffering agent and Nystatin

223

Tetracycline Hydrochloride.............................................................

Tetracycline Hydrochloride with Nystatin

Procaine Hydrochloride with Tetracycline Hydrochloride

224

Thiamine Hydrochloride.............................................................

Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride

225

Thioridazine .............................................................

—

226

Thiotepa .............................................................

—

227

Thonzonium Bromide.............................................................

Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide

228

Thonzylamine Hydrochloride.............................................................

Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride

229

Tiemonium Iodide.............................................................

—

230

Triamcinolone Acetonide.............................................................

Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide

231

Triclofos Sodium.............................................................

—

232

Trifluoperazine Hydrochloride.............................................................

—

233

Triglycerides Oil, Medium Chain.............................................................

—

234

Triglyde ............................................................. .............................................................

—

235

Trimeprazine Tartrate, B.P.C..............................................................

—

236

Trimethoprim .............................................................

Trimethoprim with Sulphamethoxazole

237

Triprolidine Hydrochloride

—

238

Vinyl Acetate .............................................................

Vinyl Pyrrolidone with Vinyl Acetate and Benzocaine

239

Vinyl Pyrrolidone .............................................................

Vinyl Acetate with Vinyl Pyrrolidone and Benzocaine

240

Viprynium Embonate.............................................................

—

241

Vitamin A .............................................................

Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A

242

Vitamin D .............................................................

Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D

243

“ ZERODOR ” .............................................................

—

244

“ ZOFF ” .............................................................

—

THIRD SCHEDULE Regulation 11

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

1. Acepifylline

2. Acetazolamide Sodium

3. Acetohexamide

4. Acetylcholine Chloride

5. Acetylcysteine

6. Acetyl Sulphafurazole

7. Acidified Golden Syrup, A.P.F. 1955

8. Acriflavine, B.P.C. 1963

9. Acrylic Resin

10. Adrenaline Hydrochloride

11. Albumaid XP

12. Alginic Acid Compound

13. Aloin, B.P.C.

14. Almond Oil Volatile Bitter, B.P.C. 1959

15. Aloxiprin

16. Aluminium Acetate Solution, B.P.C.

17. Aluminium Hydroxide Mixture, A.P.F.

18. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex

19. Aluminium Sodium Silicate

20. Amantadine Hydrochloride

21. Amaranth Solution, A.P.F.

22. Amaranth Solution, Compound, A.P.F.

23. Amaranth Solution, B.P.C.

24. Ambenonium Chloride

25. Amiloride Hydrochloride

26. Amino Acids

27. Aminogran

28. Aminosalicylic Acid

29. Amitriptyline Embonate

30. Ammonia Aromatic Spirit, B.P.C.

31. Ammonia Solution, Strong, B.P.C.

32. Ammonium Acetate Solution, Strong, B.P.C.

33. Ammonium Bicarbonate, B.P.C.

34. Amphotericin B

35. Angiotensin Amide

36. Antazoline Sulphate

37. Anti-Haemophilic Factor of Animal Origin

38. Attapulgite

39. Bacitracin Zinc

40. “ BANISH ”

41. Belladonna Suppository, B.P. 1948

42. Benzalkonium Chloride

43. Benzoin Compound Tincture, B.P.C.

44. Betahistine Hydrochloride

45. Betamethasone Acetate

46. Betamethasone Phosphate

47. Bethanechol Chloride

48. Black Snake Antivenene

49. Biperiden Hydrochloride

50. Bismuth Subgallate, B.P.C.

51. Brompheniramine Maleate

52. Brown Snake Antivenene

53. Buchu Concentrated Infusion, B.P.C. 1954

54. Cade Oil, B.P.C.

55. Caffeine and Sodium Benzoate, B.P.C. 1954

56. Caffeine Citrate, B.P.C. 1959

57. Calcium Di-Oxytetracycline

58. Calcium Gluconogalactogluconate

59. Calcium Lactate-Gluconate

60. Capreomycin Sulphate

61. Capsicum Ointment, B.P.C.

62. Capsicum Oleoresin

63. Carbenoxolone Sodium

64. Carbinoxamine Maleate

65. Cardamom Aromatic Tincture, B.P.C.

66. Catechu Tincture, B.P.C.

67. Cephalexin Monohydrate

68. Ceratonia, B.P.C. 1949

69. Cetomacrogol Emulsifying Wax, B.P.C.

70. Charcoal

71. Chloramine, B.P.C.

72. Chloramphenicol Palmitate, B.P.C.

73. Chloramphenicol Stearate

74. Chloramphenicol Succinate

75. Chlorhexidine Acetate

76. Chlorhexidine Gluconate

77. Cholestyramine

78. Clemastine Hydrogen Fumarate

79. Clemizole Hydrochloride

80. Clemizole Tannate

81. Clindamycin Hydrochloride

82. Clonidine Hydrochloride

83. Clopamide

84. Clorexolone

85. Coal Tar, B.P.C.

86. Coal Tar Solution Strong, B.P.C.

87. Cochineal Tincture, B.P. 1948

88. Coconut Oil, B.P.C. 1949

89. Colaspase

90. Colophony Ointment, B.P.C. 1959

91. Copper Sulphate, B.P.C.

92. Creosote, B.P.C. 1959

93. Cyclothiazide

94. Cycrimine Hydrochloride

95. Cymogran

96. Cytarabine Hydrochloride

97. Danthron

98. Daunorubicin

99. Death Adder Antivenene

100. Debrisoquine

101. Demecarium Bromide

102. Deslanoside

103. Dexamethasone Metasulphobenzoate

104. Dexamethasone Sodium Phosphate

105. Dexchlorpheniramine Maleate

106. Dextrans

107. Dextriferron

108. Dextrose Polymer

109. Diazoxide

110. Dibenzepin Hydrochloride

111. Diethanolamine Fusidate, B.P.C.

112. Dihydroergotamine Mesylate

113. Dihydroergotoxine Mesylate

114. Dihydrostreptomycin Sulphate, B.P. 1958

115. Dimethicone, B.P.C.

116. Dimethindene Maleate

117. Dioctyl Sodium Sulphosuccinate, B.P.C.

118. Diphenylpyraline Hydrochloride

119. Diphtheria Vaccine (Purified toxoid aluminium phosphate) diluted

120. Diphtheria and Tetanus Vaccine, Adult

121. Dipyridamole

122. Doxepin Hydrochloride

123. Doxylamine Succinate

124. Droperidol

125. Ephedrine, B.P.C.

126. Epicillin

127. Erythrityl Tetranitrate

Third Schedule—continued

128. Erythromycin Ethyl Succinate

129. Erythromycin Glucoheptonate

130. Erythromycin Lactobionate

131. Ethanolamine Oleate

132. Ethoxzolamide

133. Ethylidene Dicoumarin

134. Ethylnoradrenaline Hydrochloride

135. Ethyloestrenol

136. Ferric Hydroxide

137. Ferrous Aminoacetosulphate

138. Ferrous Phosphate Compound, Syrup, B.P.C.

139. Fluclorolone Acetonide

140. Flumethasone Pivalate

141. Fluorothacil Sodium

142. Fluphenazine Decanoate

143. Fluphenazine Enanthate

144. Flurandrenolone

145. Framycetin Sulphate

146. Galactomin, Formula No. 17

147. Galactomin, Formula No. 19

148. Gall and Opium Ointment, B.P.C. 1963

149. Gelsemium Tincture, B.P.C.

150. Ginger Syrup, B.P.C.

151. Glibenclamide

152. Glucagon Hydrochloride

153. Glucose and Ketone Indicator

154. Glucose Indicator—Blood

155. Glucose Indicator—Urine

156. Glycerophosphate Compound Syrup, A.P.F.

157. Glycopyrronium Bromide

158. Glymidine

159. Goat’s Milk, Dehydrated

160. Goat’s Milk, Whole (Sterilised)

161. Gramicidin

162. Guaiphenesin, B.P.C.

163. Hamamelis Liquid Extract, B.P.C.

164. Heparin Calcium

165. Hexocyclium Methylsulphate

166. Haemodialysis Fluid—Concentrate

167. Hexamine Hippurate

168. Hydrargaphen

169. Hydromorphone Hydrochloride

170. Hydroxyurea

171. Hyoscine Butylbromide

172. Hyoscine Methobromide

173. Hypophosphorous Acid, Dilute, B.P.C. 1963

174. Hypromellose 4500

175. Ibuprofen

176. Influenza Vaccine—Sub Unit Type (Desoxycholate Treated)

177. Injection of Amino Acids with Sorbitol and Alcohol

178. Injection of Casein Hydrolysate with Laevulose and Alcohol

179. Injection of Dextran with Dextrose

180. Injection of Potassium Chloride with Sodium Lactate and Dextrose

181. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose

182. Injection of Sodium Chloride with Sodium Lactate and Dextrose

183. Insect Allergen Extract—Honey Bee

184. Insect Allergen Extract—Jumper Ant

185. Insect Allergen Extract—Paper Wasp

186. Insulin Injection, specially purified

187. Insulin Isophane Injection, specially purified

188. Insulin Injection, Special P (Pig)

189. Intraperitoneal Dialysis Solutions

190. Invert Sugar

191. Iron Polymaltose Complex

192. “ ISOMIL ”

193. Isoprenaline Hydrochloride

194. Isopropamide Iodide

195. Kanamycin Sulphate, B.P.C.

196. “ KETOVITE ” Liquid

197. “ KETOVITE ” Tablets

198. Lactulose

199. Lanatoside-C

200. Lauryl Dimethyl Benzyl Ammonium Chloride

201. Lavender Spike Oil, B.P.C.

202. Lead Subacetate Dilute Solution

203. Lead Subacetate Strong Solution, B.P.C.

204. Lemon Oil Terpeneless, B.P.C.

205. Lemon Tincture, B.P. 1958

206. Leucovorin

207. Lipopancreatin

208. Lobelia Ethereal Tincture, B.P.C.

209. Locasol

210. Lofenalac

211. Lypressin

212. Magenta, B.P.C.

213. Magnesium-Aluminium Hydroxide

214. Magnesium Hydroxide, B.P.C.

215. Maphenide Acetate

216. Mebeverine Hydrochloride

217. Mebhydrolin Napadisylate, B.P.C.

218. Medroxyprogesterone Acetate

219. Medrysone

220. Mepenzolate Bromide

221. Mercaptomerin Sodium

222. Mercuric Chloride, B.P.C.

223. Metaraminol Bitartrate

224. Methaqualone Hydrochloride

225. Methdilazine Hydrochloride

226. Methenamine Mandelate

227. Methenolone Acetate

228. Methoxamine Hydrochloride, B.P.C.

229. Methsuximide

230. Methyclothiazide

231. Methylphenobarbitone, B.P.C. 1963

232. Methylprednisolone Acetate

233. Methylprednisolone Sodium Succinate

234. Methysergide Maleate

235. Minocycline Hydrochloride

236. Morphine Tartrate

237. Myrrh Tincture, B.P.C.

238. Nalidixic Acid, B.P.C.

239. Nandrolone Hexoxyphenyl Propionate

240. Natamycin

241. Neomycin Undecenoate

242. Nitromin

243. Norgestrel

244. Nutramigen

245. Octatropine Methylbromide

246. Oestradiol Valerate

247. Oestrone, B.P.C. 1954

248. Oily Ophthalmic Vehicle, A.P.F. 1955

249. Orange Syrup, B.P.C.

250. Orange Tincture, B.P.C.

251. Oxazepam

252. Oxethazaine

253. Oxprenolol Hydrochloride

254. Oxycodone Pectinate

Third Schedule—continued

255. Oxymel, B.P.C.

256. Oxymel of Squill, B.P.C.

257. Oxymetholone

258. Oxyphenonium Bromide

259. Oxytetracycline

260. Oxytocin

201. Pancreatin Enzyme, U.S.N.F. XII

262. Papaveretum, B.P.C.

263. Paraben Ophthalmic Phosphate Buffer, A.P.F.

264. Paraben Ophthalmic Vehicle, A.P.F. 1955

265. Paraffin Liquid Light, B.P.C. 1963

266. Paramethasone Acetate

267. Pectin

268. Penicillinase

269. Penicillin Benethamine, B.P.C.

270. Pentacrythritol Tetranitrate, diluted, B.P.C.

271. Pentazocine Lactate

272. Penthienate Methobromide

273. Pentobarbitone

274. Pericyazine

275. Pheniramine Maleate

276. Pheniramine Para-Aminosalicylate

277. Phenol Ointment, B.P. 1948

278. Phenoxymethylpenicillin, Benzathine

279. Phenoxymethylpenicillin, Hydrabamine

280. Phensuximide, B.P.C.

281. Phenthimentonium

282. Phenytoin, B.P.C.

283. Phthalylsulphacetamide

284. Physostigmine, B.P.C.

285. Pilocarpine Hydrochloride

286. Pipenzolate Methobromide

287. Pituitary Hormone, Follicle-stimulating, Human

288. Pituitary Hormone, Growth, Human

289. Pituitary (Posterior Lobe) Powdered, B.P.C.

290. Pizotifen Malate

291. “ PK AID I ”

292. “ PK AID II ”

293. Plasma Substitute (Polypeptide)

294. Polyisobutylene

295. Polyoestradiol Phosphate

296. Polyvinyl Alcohol

297. Potassium Chlorate, B.P.C.

298. Potassium Effervescent Tablets 299. Practolol

300. Prednisolone Acetate

301. Prednisolone Sodium Succinate

302. Prednisolone Steaglate

303. Prednisolone Tertiary Butyl Acetate

304. Prindolol

305. Procarbazine Hydrochloride

306. Prochlorperazine

307. Proscillaridin

308. Prosobee

309. Pseudoephedrine Hydrochloride

310. Pumilio Pine Oil, B.P.C.

311. Pyrantel Embonate

312. Pyridine Aldoxime Methiodide

313. Quillaia Tincture, B.P.C.

314. Quinethazone

315. Quinidine Bisulphate

316. Raspberry Syrup, B.P.C.

317. Rauwolfia Alkaloids

318. Rauwolfia Serpentina, B.P.C.

319. Red Back Spider Antivenene

320. Rolitetracycline

321. Rosemary Oil, B.P.C.

322. Salbutamol Sulphate

323. Salicylamide

324. Secbutobarbitone Sodium

325. Senega, Concentrated Infusion, B.P.C. 1968

326. Siberian Fir Oil, B.P.C. 1949

327. Silver Protein, B.P.C.

328. Silver Protein Mild, B.P.C.

329. Snake Bite Antivenene—Polyvalent

330. Sobee

331. Sodium Gluconate

332. Sodium Hypochlorite Solution, Strong, B.P.C.

333. Sodium Lactate

334. Sodium Lactate Compound Injection, B.P. with Dextrose

335. Sodium Nitroprusside

336. Sodium Tauroglycocholate, B.P.C. 1554

337. Sorbide Nitrate

338. Soyalac

339. Spectinomycin Dihydrochloride Pentahydrate

340. Squill Tincture, B.P.C.

341. Stanolone

342. Stanozolol

343. Stearic Acid, B.P.C.

344. Sterculia

345. Stilboestrol Diphosphate

346. Stone Fish Antivenene

347. Streptokinase

348. Strychnine, B.P.C. 1959

349. Sulphaphenazole, B.P.C.

350. Sulphasalazine

351. Sulphasymazine

352. Sulphurated Potash, B.P.C.

353. Sulphur Sublimed, B.P.C.

354. Surgical Cement

355. Surgical Cement Solvent

356. Tacrine

357. Taipan Antivenene

358. Tartrazine, B.P.C. 1954

359. Terbutaline Sulphate

360. “ TERIC N8 ”

361. Testosterone Decanoate

362. Testosterone Enanthate

363. Testosterone Isocaproate

364. Tetracosactrin

365. Tetracycline, B.P.C.

366. Thiabendazole

367. Thiethylperazine Malate

368. Thiethylperazine Maleate

369. Thiopropazate Hydrochloride

370. Thioridazine

371. Thonzonium Bromide

372. Thonzylamine Hydrochloride

373. Thyrotropin

374. Tiemonium Iodide

375. Tiger Snake Antivenene

376. Titanium Dioxide, B.P.C.

377. Tolazamide

378. Tragacanth Mucilage

379. Tridihexethyl Chloride

380. Triethanolamine, B.P.C.

381. Triglycerides Oil, Medium Chain

382. Triglyde

383. Trimeprazine Tartrate, B.P.C.

384. Trolnitrate Phosphate

385. Typhoid Vaccine

Third Schedule—continued

386. Vancomycin Hydrochloride

387. Vanillin

388. Vasopressin Tannate.

389. Verapamil

390. Vincristine Sulphate

391. Vinyl Acetate

392. Vinyl Pyrrolidone

393. Vitamin A

394. Vitamin D

395. “ ZERODOR ”

396. Zinc Gelatin, B.P.C.

397. “ ZOFF ”

_______________

FOURTH SCHEDULE Regulation 12

Additives

 

1. Acetone, B.P.C.

2. Alcohol (95%), B.P.

3. Arachis Oil, B.P.

4. Amethocaine Hydrochloride, B.P.

5. Camphor, B.P.

6. Carmine Solution, A.P.F.

7. Castor Oil, B.P.

8. Citronella Oil, B.P.C.

9. Chlorhexidine Gluconate Solution, B.P.

10. Chloroform, B.P.

11. Concentrated Anise Water, B.P.C.

12. Concentrated Cinnamon Water, B.P.C.

13. Concentrated Peppermint Water, B.P.

14. Dextrose Monohydrate, B.P.

15. Dilute Alcohols, B.P.

16. Ether Anaesthetic, B.P.

17. Eucalyptol, B.P.C.

18. Eucalyptus Oil, B.P.

19. Honey—Purified, B.P.C.

20. Hypromellose 4500

21. Maize Oil, B.P.

22. Methylcellulose 450

23. Olive Oil, B.P.

24. Peppermint Oil, B.P.

25. Sodium Thiosulphate, B.P.C.

26. Solution of Burnt Sugar, B.P.C. 1959

27. Solvent Ether

28. Spirit, Methylated, Industrial, B.P.

29. Syrup of Pholcodine Citrate, B.P.C. 1959

30. Turpentine Oil, B.P.

31. Xylene, B.P.C. 1949

FIFTH SCHEDULE Regulation 14

Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

1

Acetylcysteine..........................................

Cystic fibrosis (mucoviscidosis)

2

Aspirin with Paracetamol and Caffeine Tablets

Any disease or condition in a pensioner

3

Acrylic Resin............................................

Ileostomy or colostomy conditions

4

Albumaid XP............................................

With the written authority of the Director-General, phenylketonuria

5

Alginic Acid Compound Granules......

Reflux oesophagitis

6

Alginic Acid Compound Powder.........

Oesophageal reflux in infants

7

Alprenolol Injection, B.P. .....................

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

8

Alprenolol Tablets, B.P..........................

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

Treatment of severe hypertensive disease where other treatment has proved ineffective

9

  

Amantadine Hydrochloride...................

  

With the written authority of the Director-General, the treatment of Parkinson’s disease caused otherwise than by treatment with a drug

10

(1) Aminocaproic Acid, B.P..................

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Aminocaproic Acid Injection, B.P.

11

Aminogran................................................

With the written authority of the Director-General, phenylketonuria

12

Aminosalicylic Acid...............................

Tuberculosis

13

Amphotericin B Injection......................

Systemic mycoses

14

(1) Ampicillin Capsules, B.P.................

Infections by organisms sensitive to Ampicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally—

(2) Ampicillin Injections and Tablets..

(3) Ampicillin Trihydrate, B.P., with Purified Water, B.P........................

Benzylpenicillin

Phenoxymethylpenicillin

Phenethicillin

Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Ampicillin

Urinary tract infections where the patient is sensitive to sulphonamides

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

15

Ascorbic Acid Tablets, B.P...................

Any disease or condition in a pensioner

16

Azathioprine ............................................

With the written authority of the Director-General—

Anaemia, autoimmune haemolytic

Arthritis, rheumatoid with vasculitis or visceral complications

Crohn’s disease

Dermatomyositis

Granulomatosis, Wegener’s

Hepatitis, active, chronic

Lupus erythematosus, systemic

Nephritis

Nephrotic syndrome

Organ transplant

Polyarteritis nodosa

Scleroderma

Thrombocytopenic purpura

Ulcerative colitis

17

“ BANISH ” ............................................

Ileostomy or colostomy conditions

18

Benzathine Penicillin, B.P.....................

Prophylaxis of recurrent streptococcal infections (including rheumatic fever)

19

Benzoin Compound Tincture, B.P.C., aerosol spray

Ileostomy or colostomy conditions

20

Benzylpenicillin Injection, 5,000,000 units

Bacterial endocarditis or septicaemia

21

Benzylpenicillin Injection, 10,000,000 units

Bacterial endocarditis or septicaemia

Gastrointestinal surgery

22

(1) Benzylpenicillin with Streptomycin Sulphate

Endocarditis due to streptococcus faecalis or streptococcus viridans

(2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate

23

Betahistine Hydrochloride

Meniere’s syndrome

24

Betamethasone Acetate with Betamethasone Injection

Alopecia areata

Granulomata, dermal

Intra-articular use

Keloid

Lichen planus hypertrophic

Lichen simplex chronicus

Lupus erythematosus, chronic discoid

Uveitis

With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy

25

Bethanechol Chloride.............................

Urinary retention due to a neurogenic atonic bladder

26

Busulphan Tablets, B.P..........................

Treatment in malignant neoplasia

27

(1) Calciferol Tablets, Strong, B.P.

With the written authority of the Director-General— Hypoparathyroidism

(2) Calciferol, B.P.

Osteomalacia following gastrectomy or severe steatorrhoea

Vitamin D-resistant rickets

28

Calcium Aminosalicylate

Tuberculosis

29

Calcium Carbonate, B.P., with Calcium Lactate-Gluconate

Hypocalcaemia

Hypoparathyroidism

Osteoporosis

30

Calcium Carbonate, B.P., with Citric Acid, B.P. Compound Effervescent Tablets

Hypocalcaemia

Hypoparathyroidism

Osteoporosis

31

Calcium Dioxytetracycline

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets

 

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

32

Calcium Gluconogalacto-gluconate Tablets

Hypocalcaemia

Hypoparathyroidism

Osteoporosis

33

Capreomycin Sulphate ........................

Tuberculosis

34

Carbamazepine Tablets B.P.

Epilepsy

Trigeminal neuralgia

35

Carbenicillin Sodium............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent

36

Carbenoxolone Sodium.......................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, gastric ulcer where a radiological examination or other appropriate tests have confirmed the presence of a gastric ulcer

37

(1) Cephalexin Monohydrate

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent

(2) Cephalexin Monohydrate with Purified Water, B.P.

38

Cephaloridine.........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent

39

Cephalothin Sodium.............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent

40

Ceratonia ...............................................

Oesophageal reflux in infants

41

Charcoal Tablets...................................

Ileostomy or colostomy conditions

42

Chlorambucil Tablets, B.P...................

With the written authority of the Director-General—

Anaemia, autoimmune, haemolytic

Arthritis, rheumatoid with vasculitis or visceral complications

Crohn’s disease

Dermatomyositis

Granulomatosis, Wegener’s

Hepatitis, active, chronic

Lupus erythematosus, systemic

Malignant disease including leukaemia

Nephritis

Nephrotic syndrome

Polyarteritis nodosa

Scleroderma

Thrombocytopenic purpura

Ulcerative colitis

43

Chloramine Deodorant Tablets and powder

Ileostomy or colostomy conditions

44

(1) Chloramphenicol Capsules, B.P.

Bacterial meningitis

Intraocular infections

(2) Chloramphenicol Injections

Rickettsioses

Typhoid

(3) Chloramphenicol Oral Suspension

The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient

  

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

45

Chlorotrianisene Tablets

Carcinoma of the prostate

46

(1) Chlorpromazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Chlorpromazine Injection, B.P.

Major psychoses including—

Major organic psychoses

(3) Chlorpromazine Tablets, B.P.

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct disorders in patients who have not attained the age of sixteen years

47

Chlortetracycline Hydrochloride

Any disease or condition in a pensioner

48

Cholestyramine .....................................

With the written authority of the Director-General—

Bile salt malabsorption associated with ileal resection or proven ileal disease

Pruritis associated with partial biliary obstruction not responding to other therapy

Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type 11) not responding to other therapy

A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type 11) in patients who respond to treatment with cholestyramine but do not respond to other therapy

49

Clindamycin Hydrochloride

Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin, or a derivative of penicillin

Osteomyelitis

50

Clofibrate................................................

With the written authority of the Director-General—

Diabetic retinopathy (exudative)

Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy

A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report

51

(1) Cloxacillin Sodium, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Cloxacillin Capsules, B.P.

(3) Cloxacillin Sodium, B.P., with Purified Water, B.P.

With the written authority of the Director-General, serious infections where bacteriological evidence confirms the presence of penicillinase-producing staphylococci

Osteomyelitis

52

(1) Codeine Phosphate with Aspirin Soluble Tablets

Any disease or condition in a pensioner

(2) Codeine Phosphate with Aspirin Tablets

(3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets

(4) Codeine Phosphate with Aspirin and Paracetamol Tablets

(5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets

53

Colaspase...............................................

Acute leukaemia

Malignant neoplasia

54

Colistin Sulphomethate Sodium, B.P., for injection

Pyocyancus infection, other gram-negative infections where no other drug is effective

   

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

55

Cyanocobalamin Injection, B.P.

Pernicious anaemia and other proven Vitamin B-12

deficiencies

Post gastrectomy treatment

Sub-acute combined degeneration of the cord

Neuroblastoma

56

(1) Cyclophosphamide Tablets, B.P.

With the written authority of the Director-General—

Anaemia, autoimmune, haemolytic

(2) Cyclophosphamide, B.P.

Arthritis, rheumatoid with vasculitis or visceral complications

Crohn’s disease

Dermatomyositis

Granulomatosis, Wegener’s

Hepatitis, active, chronic

Lupus erythematosus, systemic

Malignant disease, including leukaemia

Nephritis

Nephrotic syndrome

Polyarteritis nodosa

Scleroderma

Thrombocytopenic purpura

Ulcerative colitis

57

Cycloserine Capsules, B.P...................

Tuberculosis

58

Cymogran ..............................................

With the written authority of the Director-General,

phenylketonuria

59

(1) Cyproheptadine Hydrochloride, B.P.

Allergic rhinitis

Allergic dermatoses

(2) Cyproheptadine Tablets, B.P.

Migraine

60

Cytarabine Hydrochloride...................

Acute leukaemia

Malignant neoplasia

61

Daunorubicin ........................................

Acute leukaemia

Malignant neoplasia

62

Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and “TERIC N8”)

Ileostomy or colostomy conditions

63

Deoxycortone Acetate, B.P.

Adrenal cortical hypofunction

64

Desferrioxamine Mesylate..................

Acute iron poisoning

Hepatolenticular degeneration

65

(1) Dextromoramide Tablets, B.P.

Treatment in malignant neoplasia

(2) Dextromoramide Tartrate, B.P.

66

Dextrose Polymer..................................

With the written authority of the Director-General, phenylketonuria

67

Diazoxide................................................

Hypertensive crisis

68

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

Vomiting in pregnancy

69

(1) Dihydroergotoxine Mesylate Tablets

For the treatment of patients who have suffered an attack of

paralytic poliomyelitis

(2) Dihydroergotoxine Mesylate Injection

70

Dihydrotachysterol...............................

Hypoparathyroidism

71

Dimethicone Aerosol Spray

Ileostomy or colostomy conditions

72

Dimethicone Creams............................

Use with surgical appliances

73

(1) Dioctyl Sodium Sulphosuccinate

Any disease or condition in a pensioner

(2) Dioctyl Sodium Sulphosuccinate with Danthron

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

74

Dipyridamole.........................................

Supplementing anticoagulants in—

Biopsy proven glomerulonephritis

Microangiopathic renal disease

Renal allograft

Patients with cardiac prosthesis

75

Doxycycline Hydrochloride Suspension

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets

76

Droperidol .............................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

77

(1) Epicillin Capsules

Infections by organisms sensitive to Epicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally—

(2) Epicillin with Purified Water, B.P.

Benzylpenicillin

Phenoxymethylpenicillin

Phenethicillin

Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Epicillin

Urinary tract infections where the patient is sensitive to sulphonamides

78

Ethacrynic Acid.....................................

Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome

Fluid retention associated with other conditions and not responding to thiazides

79

Ethionamide...........................................

Tuberculosis

80

Ethyloestrenol........................................

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

Osteomalacia following gastrectomy

81

Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P.

Prophylactic use during pregnancy

82

Fludrocortisone Tablets, B.P.

Adrenal cortical hypoplasia including Addison’s disease

Orthostatic hypotension

Total adrenalectomy

83

Fluorouracil Sodium

Treatment in malignant neoplasia

84

Fluoxymesterone Tablets, B.P.

Eunuchism

Eunuchoidism

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Proven aplastic anaemias

85

(1) Fluphenazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Fluphenazine Tablets, B.P.

Major psychoses including—

(3) Fluphenazine Enanthate

Major organic psychoses

(4) Fluphenazine Decanoate

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

86

(1) Folic Acid, B.P.

Cystic fibrosis

(2) Folic Acid Tablets, B.P. 5 mg.

Proven folic acid deficiency

Sprue or the sprue-like syndrome

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

87

Folic Acid Tablets, B.P. 0.5 mg.

Cystic fibrosis

Pregnancy

88

Framycetin Sulphate Injection

Sub-conjunctival injection in the treatment of serious ocular inflammation

89

Framycetin Sulphate Tablets

Bowel sterilization preparatory to major surgery

90

Frusemide Tablets, B.P........................

Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome

Fluid retention associated with other conditions and not responding to thiazides

91

Galactomin Formula No. 17

With the written authority of the Director-General—

Galactosaemia

Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years

92

Galactomin Formula No. 19

With the written authority of the Director-General, glucose-galactose malabsorption

93

Gentamicin Sulphate............................

With the written authority of the Director-General—

Infections where positive bacteriological evidence confirms that gentamicin is the most appropriate antibiotic

Septicaemia including suspected septicaemia

94

Glucose Indicator—Blood..................

Diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing

Hypoglycaemia of infancy

95

Goat’s Milk, Dehydrated.....................

With the written authority of the Director-General, cow’s milk allergy in children under the age of four years

96

Goat’s Milk, Whole (Sterilized)

With the written authority of the Director-General, cow’s milk allergy in children under the age of four years

97

(1) Griseofulvin, B.P.

With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light

(2) Griseofulvin Tablets, B.P.

98

Halibut Liver Oil Capsules..................

Any disease or condition in a pensioner

99

Haloperidol.............................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Major psychoses including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

100

Heparin Calcium...................................

Any disease or condition in a patient receiving treatment

in or at an approved hospital

101

Hydrocortisone Acetate Injection, B.P.

Alopecia areata

Granulomata, dermal

Intra-articular use

Keloid

Lichen planus hypertrophic

Lichen simplex chronicus

Lupus erythematosus, chronic discoid

102

Hydrocortisone Sodium Succinate Injection, 100 mg.

Acute medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy

103

Hydrocortisone Sodium Succinate Injection, 250 mg. and 500 mg.

Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

104

Hydroxocobalamin Injection, B.P.

Pernicious anaemia and other proven Vitamin B-12

deficiencies

Post gastrectomy treatment

Sub-acute combined degeneration of the cord

Neuroblastoma

105

Hydroxyprogesterone Injection, B.P.

Carcinoma of the endometrium

106

Hydroxyurea..........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

107

Ibuprofen................................................

Rheumatoid arthritis where salicylates are contra-indicated or ineffective

Osteoarthritis where salicylates are contra-indicated or ineffective

108

Idoxuridine ............................................

Infections caused by Herpes Simplex Virus

109

Influenza Vaccine ................................

For prophylaxis of pensioners only

110

Insect Allergen Extract—Honey Bee

Severe constitutional reaction to bee stings

111

Insect Allergen Extract—Jumper Ant

Severe constitutional reaction to jumper ant stings

112

Insect Allergen Extract—Paper Wasp

Severe constitutional reaction to wasp stings

113

“ISOMIL”...............................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children who have not attained the age of four years

114

Isoniazid Tablets, B.P...........................

Tuberculosis

115

Isoprenaline Hydrochloride Tablets, 30 mg.

Stokes-Adams Syndrome

116

Kanamycin Sulphate Injections

Infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic

Septicaemia, including suspected septicaemia

117

(1) “ KETOVITE ” Liquid

With the written authority of the Director-General—

(2) “ KETOVITE ” Tablets

Galactosaemia

Persistent monosaccharide intolerance

Phenylketonuria

Tyrosinosis (hereditary)

118

Lactulose ................................................

Hepatic coma or pre-coma (chronic portosystemic encephalopathy)

119

Leucovorin.............................................

Antidote to folic acid antagonists

120

(1) Levodopa Capsules, B.P.

With the written authority of the Director-General, treatment of Parkinson’s Disease

(2) Levodopa Tablets, B.P.

121

Lignocaine Injection, B.P....................

Cardiac arrhythmias

122

(1) Lincomycin Hydrochloride, B.P.

Gram positive coccal infections where these cannot be safely and effectively treated with a penicillin

(2) Lincomycin Capsules, B.P.

Osteomyelitis

(3) Lincomycin Injection, B.P.

123

Liothyronine Tablets, B.P....................

Myxoedema

124

Lithium Carbonate Tablets, B.P.

With the written authority of the Director-General, manic depression

125

Locasol....................................................

With the written authority of the Director-General, Hypercalcaemia in children under the age of two years

126

Lofenalac...............................................

With the written authority of the Director-General, phenylketonuria

127

Lypressin Nasal Spray.........................

Diabetes insipidus

128

Maphenide Acetate...............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

129

Medroxyprogesterone Acetate Tablets, 2.5 mg.

Precocious puberty

Turner’s syndrome

130

Medroxyprogesterone Acetate Tablets, 10 mg.

Precocious puberty

Turner’s syndrome

 

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

131

Medroxyprogesterone Acetate Tablets, 100 mg.

Carcinoma of the breast

Carcinoma of the endometrium

Hypernephroma

132

Medroxyprogesterone Acetate Injections, 50 mg. in 1 ml. or 250 mg. in 5 ml.

Carcinoma of the endometrium

Hypernephroma

133

Medroxyprogesterone Acetate Injections, 150 mg. in 1 ml.

Carcinoma of the endometrium

Hypernephroma

Precocious puberty

134

Megestrol Acetate, B.P., with Ethinyloestradiol, B.P.

Severe acne in females

Hirsutism in females

Sexual infantilism in females

135

Melphalan Tablets, B.P........................

Treatment in malignant neoplasia

136

Mercaptopurine Tablets, B.P.

Allergic granulomatous angiitis

Lupus erythematosus

Nephrotic syndrome

Periarteritis (nodosa)

Treatment in malignant neoplasia

137

Methacycline Hydrochloride, B.P.

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets

138

(1) Methandienone Tablets, B.P.

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

(2) Methenolone Acetate

Intermittent use for patients on long-term treatment with corticosteroids

139

Methicillin Sodium, B.P., for Injection

Proven or suspected staphylococcal septicaemia

146

(1) Methotrexate Tablets

With the written authority of the Director-General—

(2) Methotrexate Injection

Malignant neoplasia

Pemphigus vulgaris

Psoriasis, severe, generalised

141

Methylprednisolone Acetate Retention Enema

With the written authority of the Director-General—

Colitis, ulcerative, proven by sigmoidoscopy or radiological report

Proctitis, proven by sigmoidoscopy

142

Methylprednisolone Acetate Injection

Intra-articular use

143

Methyltestosterone Tablets, B.P., 5 mg.

Hypogonadism in patients who have not attained the age of sixteen years

144

(1) Methyltestosterone Tablets, B.P., 25 mg. or 50 mg.

Carcinoma of the breast

Eunuchism

(2) Methyltestosterone, B.P.

Eunuchoidism

Klinefelter’s syndrome (seminiferous tubule dysgenesis)

145

Methysergide Maleate.........................

Carcinoid syndrome

Treatment of severe recalcitrant migraine where other treatment has failed

146

Metyrapone Capsules, B.P...................

Any disease or condition in a patient receiving treatment in or at an approved hospital

147

Morphine Sulphate, B.P. with Tacrine Tablets

Severe intractable pain

148

Mustine Hydrochloride Injection

Treatment in malignant neoplasia

149

Nalidixic Acid........................................

Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nalidixic Acid or where the patient is sensitive to sulphonamides

 

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

150

Nandrolone Decanoate........................

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

Severe osteoporosis due to proven pancreatitis

151

Nandrolone Hexoxyphenyl Propionate

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for patients on long-term treatment with corticosteroids

Intermittent use for corticosteroid-induced osteoporosis

152

Nandrolone Phenylpropionate Injection, B.P.

Carcinoma of the breast

With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis

153

Neomycin Sulphate Powder

With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)

154

Neomycin Tablets, B.P.........................

Bowel sterilization preparatory to major surgery

Encephalopathy, hepatic

Enteropathogenic E. coli infections in infants

155

Nicotinic Acid Tablets, B.P.

Any disease or condition in a pensioner

156

(1) Nitrofurantoin Tablets, B.P.

Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nitrofurantoin or where the patient is sensitive to sulphonamides

(2) Nitrofurantoin Oral Suspension

157

Nitromin..................................................

Treatment of malignant neoplasia

158

Norethisterone Acetate, B.P.

Carcinoma of the breast

159

Norethisterone Tablets, B.P.

Endometriosis

Metropathia haemorrhagica

Precocious puberty

Turner’s syndrome

160

Nutramigen.............................................

With the written authority of the Director-General—

Cow’s milk allergy in children under the age of four years

Cystic fibrosis (mucoviscidosis)

Galactosaemia

Lactose intolerance

161

Oxprenolol Hydrochloride Tablets

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Treatment of severe hypertensive disease where other treatment has proven ineffective

162

Oxprenolol Hydrochloride Injection

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

163

Oxycodone Pectinate............................

Treatment in malignant neoplasia

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

164

Oxymetholone.......................................

With the written authority of the Director-General—

Proven aplastic anaemias

Myelosclerosis

165

Oxytetracycline Capsules, B.P. 100 mg.

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

166

Oxytetracycline Hydrochloride Ointment

Any disease or condition in a pensioner

167

(1) Pancreatin, B.P.

Cystic fibrosis (mucoviscidosis)

(2) Pancreatin Enzyme 4X U.S.N.F.XII

Following pancreatico-duodenectomy

Pancreatic steatorrhoea

(3) Pancrelipase

168

(1) Paraffin Liquid Emulsion

Any disease or condition in a pensioner

(2) Paraffin Liquid Emulsion with Phenolphthalein

169

Penicillamine..........................................

With the written authority of the Director-General—

Acute heavy metal intoxication

Cystinosis

Cystinuria with calculus formation

Haemoglobinuria, paroxysmal cold

Wilson’s disease (hepatolenticular degeneration)

170

(1) Pericyazine Mesylate

Any disease or condition in a patient receiving treatment

in or at an approved hospital

(2) Pericyazine

Major psychoses, including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct, disorders in patients who have not attained the ape of sixteen years

171

Phytomenadione Injection, 10 mg. per ml.

Antidote to anticoagulants

Haemorrhagic diathesis associated with malabsorption

172

Phytomenadione Injection, B.P., 1 mg. in 1 ml.

Antidote to anticoagulants

Haemorrhage, diathesis associated with malabsorption

Suspected cerebral trauma of the new born

Haemorrhagic disease of the new born

173

Pituitary, Posterior Lobe, Insufflation

Diabetes insipidus

174

Pizotifen Malate....................................

The treatment of severe migraine in a patient whose attacks of migraine do not respond to treatment by other therapeutic agents

175

(1) “PK AID I”

With the written authority of the Director-General, phenylketonuria

(2) “PK AID II”

176

Plasma Substitute (Polypeptide)

Any disease or condition in a patient receiving treatment in or at an approved hospital

177

Polyisobutylene.....................................

Ileostomy or colostomy conditions

178

Polymyxin D. Sulphate Powder

With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)

179

Polyoestradiol Phosphate....................

Carcinoma of the breast

Carcinoma of the prostate

180

Practolol Injection................................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

181

Practolol Tablets...................................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

182

Prednisolone Sodium Phosphate Retention Enema and Suppository

With the written authority of the Director-General—

Ulcerative colitis proven by sigmoidoscopy or radiological report

Proctitis proven by sigmoidoscopy

183

(1) Prednisolone Acetate Injection

Intra-articular use

(2) Prednisolone Butyl Acetate Injection

184

Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.

Corneal grafts

Uveitis

185

Prednisolone Sodium Phosphate Injection, B.P.

Acute medical or surgical crisis

Prophylactic therapy before, during and after surgical

procedures for patients requiring or recently subjected to steroid therapy

186

Prednisolone Sodium Succinate Injection

Acute medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy

187

Prindolol Injection................................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

188

Prindolol Tablets...................................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

The treatment of severe hypertensive disease where other treatment has proved ineffective

189

Procarbazine Hydrochloride

Treatment in malignant neoplasia

190

Promethazine Theoclate Tablets, B.P.

Vomiting in pregnancy

191

Propranolol Injection, B.P...................

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

 

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act.

192

Propranolol Tablets, B.P......................

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

The treatment of severe hypertensive disease where other treatment has proved ineffective

193

Proscillaridin...........................................

Patients intolerant of oral forms of prepared Digitalis, Digoxin and Lanatoside C

194

Prosobee..................................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

195

Pyrazinamide.........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

196

Pyridoxine Hydrochloride Tablets

Anaemia proved to be responsive to Pyridoxine

Convulsions responsive to Pyridoxine

Homocystinuria

Primary hyperoxaluria

Radiation sickness

Sideroblastic (refractory) anaemia

Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy

197

Riboflavine Tablets...............................

Any disease or condition in a pensioner

198

Senna Tablets, B.P................................

Any disease or condition in a pensioner

199

Sobee.......................................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

200

(1) Sodium Aminosalicylate Tablets, B.P.

Tuberculosis

(2) Sodium Aminosalicylate Injection

(3) Sodium Aminosalicylate Cachets

(4) Sodium Aminosalicylate with Isoniazid, B.P.

201

Sodium Cromoglycate.........................

With the written authority of the Director-General—the treatment of chronic intractable asthma

202

(1) Sodium Fusidate

With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence

(2) Diethanolamine Fusidate

203

Soyalac...................................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

204

Spironolactone Tablets, B.P.

With the written authority of the Director-General—

To supplement other diuretics when these have proved inadequate

Myasthenia gravis

Primary hyperaldosteronism

 

First Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may he prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

205

Stanolone ...............................................

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

206

Stanozolol...............................................

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

207

Sterculia..................................................

Ileostomy or colostomy conditions

208

Stilboestrol Diphosphate.....................

Carcinoma of the prostate

209

Streptokinase .........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

210

Sulphasalazine.......................................

Ulcerative colitis

211

(1) Surgical Cement

Ileostomy or colostomy conditions

(2) Surgical Cement Solvent

For use with surgical appliances

212

(1) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Carcinoma of the breast

Eunuchism

Eunuchoidism

Klinefelter’s syndrome (seminiferous tubule dysgenesis)

(2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

(3) Testosterone Implants, B.P.

(4) Testosterone Enanthate

(5) Testosterone Propionate Injection, B.P.

213

Tetanus Antitoxin, B.P. (Bovine)

Patients who have previously received an injection of equine serum

214

Tetracosactrin........................................

With the written authority of the Director-General—

Hypsarrhythmia

Treatment of patients who are being withdrawn from long-term corticosteroid therapy

215

Tetracycline Capsules, B.P., 100mg.

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

216

Tetracycline Hydrochloride, B.P., Syrup

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets

217

Tetracycline Hydrochloride with Nystatin, Capsules, 100mg., 125,000 units

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

218

Tetracycline Hydrochloride with Nystatin, Syrups

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets

219

Tetracycline with a buffering agent, Capsules, 100mg.

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

220

Tetracycline with a buffering agent, Syrups

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets

 

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

221

Tetracycline with a buffering agent and Amphotericin B

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

Treatment of patients who have attained the age of eight years and who are unable to swallow either capsules or tablets

222

Tetracycline with a buffering agent and Nystatin, B.P., Capsules, 100mg., 125,000 units

Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic

223

Thiamine Hydrochloride Tablets, B.P.

Any disease or condition in a pensioner

224

Thiopropazate Hydrochloride

With the written authority of the Director-General—

Hereditary chorea (Huntington’s)

Oral dyskinesia

Phenothiazine-induced choreo-athetosis

225

(1) Thioridazine

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Thioridazine Tablets, B.P.

Major psychoses including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Severe conduct disorders of children

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

226

Thyrotrophin..........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

227

Triamcinolone Acetonide Injection

Alopecia areata

Granulomata, dermal

Keloid

Lichen planus hypertrophic

Lichen simplex chronicus

Lupus erythematosus, chronic discoid

228

(1) Trifluoperazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Trifluoperazine Tablets, B.P.

Major psychoses including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct disorders in patients who have not attained the age of sixteen years

229

Triglycerides Oil, Medium Chain

With the written authority of the Director-General, proven malabsorption

230

Triglyde...................................................

With the written authority of the Director-General, proven malabsorption

231

Trimethoprim with Sulphamethoxazole

Infections by organisms sensitive to Trimethoprim with Sulphamethoxazole where the infection cannot be safely and effectively treated with other sulphonamides or with any of the following administered orally—

Benzylpenicillin

Phenoxymethylpenicillin

Phenethicillin

Ocular surgery

Urinary tract infections by organisms where other sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Trimethoprim with Sulphamethoxazole

 

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

232

Vancomycin Hydrochloride

Any disease or condition in a patient receiving treatment in or at an approved hospital

233

Verapamil...............................................

Cardiac arrhythmias

234

(1) Vinblastine Sulphate

Treatment in malignant neoplasia

(2) Vincristine Sulphate

235

Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray

Ileostomy or colostomy conditions

236

(1) Viomycin Sulphate

Tuberculosis

(2) Viomycin Sulphate Injection, B.P.

237

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules

Any disease or condition in a pensioner

238

“ ZERODOR ”.......................................

Ileostomy or colostomy conditions

239

“ ZOFF ” ................................................

Ileostomy or colostomy conditions

For use with surgical appliances

                       

Printed by Authority by the Government Printer of Australia

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0